Literature DB >> 21142106

Pipecolic acid derivatives as small-molecule inhibitors of the Legionella MIP protein.

Christina Juli1, Martin Sippel, Jens Jäger, Alexandra Thiele, Matthias Weiwad, Kristian Schweimer, Paul Rösch, Michael Steinert, Christoph A Sotriffer, Ulrike Holzgrabe.   

Abstract

The macrophage infectivity potentiator (MIP) protein is a major virulence factor of Legionella pneumophila, the causative agent of Legionnaires' disease. MIP belongs to the FK506-binding proteins (FKBP) and is necessary for optimal intracellular survival and lung tissue dissemination of L. pneumophila. We aimed to identify new small-molecule inhibitors of MIP by starting from known FKBP12 ligands. Computational analysis, synthesis, and biological testing of pipecolic acid derivatives revealed a promising scaffold for new MIP inhibitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142106     DOI: 10.1021/jm101156y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins.

Authors:  Darren W Begley; David Fox; Dominic Jenner; Christina Juli; Phillip G Pierce; Jan Abendroth; Muigai Muruthi; Kris Safford; Vanessa Anderson; Kateri Atkins; Steve R Barnes; Spencer O Moen; Amy C Raymond; Robin Stacy; Peter J Myler; Bart L Staker; Nicholas J Harmer; Isobel H Norville; Ulrike Holzgrabe; Mitali Sarkar-Tyson; Thomas E Edwards; Donald D Lorimer
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

Review 2.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

3.  MIP From Legionella pneumophila Influences the Phagocytosis and Chemotaxis of RAW264.7 Macrophages by Regulating the lncRNA GAS5/miR-21/SOCS6 Axis.

Authors:  Youfeng Shen; Jian Xu; Shenshen Zhi; Wenyan Wu; Yingying Chen; Qiang Zhang; Yan Zhou; Ze Deng; Wei Li
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

4.  Human lung tissue explants reveal novel interactions during Legionella pneumophila infections.

Authors:  Jens Jäger; Sebastian Marwitz; Jana Tiefenau; Janine Rasch; Olga Shevchuk; Christian Kugler; Torsten Goldmann; Michael Steinert
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

5.  Novel Cycloheximide Derivatives Targeting the Moonlighting Protein Mip Exhibit Specific Antimicrobial Activity Against Legionella pneumophila.

Authors:  Janine Rasch; Martin Theuerkorn; Can Ünal; Natascha Heinsohn; Stefan Tran; Gunter Fischer; Matthias Weiwad; Michael Steinert
Journal:  Front Bioeng Biotechnol       Date:  2015-03-27

6.  Structural Genomics Support for Infectious Disease Drug Design.

Authors:  Robin Stacy; Wayne F Anderson; Peter J Myler
Journal:  ACS Infect Dis       Date:  2015-01-20       Impact factor: 5.084

7.  Room temperature synthesis and antibacterial activity of new sulfonamides containing n,n-diethyl-substituted amido moieties.

Authors:  Olayinka O Ajani; Oluwole B Familoni; Feipeng Wu; Johnbull O Echeme; Zheng Sujiang
Journal:  Int J Med Chem       Date:  2012-10-17

8.  Unusual Inner-Salt Guaiazulene Alkaloids and bis-Sesquiterpene from the South China Sea Gorgonian Muriceides collaris.

Authors:  Pinglin Li; Xiaoling Liu; Hongyan Zhu; Xuli Tang; Xuefeng Shi; Yonghong Liu; Guoqiang Li
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

Review 9.  Update on the Neisseria Macrophage Infectivity Potentiator-Like PPIase Protein.

Authors:  Myron Christodoulides
Journal:  Front Cell Infect Microbiol       Date:  2022-03-22       Impact factor: 5.293

10.  Broad-spectrum in vitro activity of macrophage infectivity potentiator inhibitors against Gram-negative bacteria and Leishmania major.

Authors:  Jua Iwasaki; Donald D Lorimer; Mirella Vivoli-Vega; Emily A Kibble; Christopher S Peacock; Jan Abendroth; Stephen J Mayclin; David M Dranow; Phillip G Pierce; David Fox; Maria Lewis; Nicole M Bzdyl; Sofie S Kristensen; Timothy J J Inglis; Charlene M Kahler; Charles S Bond; Anja Hasenkopf; Florian Seufert; Jens Schmitz; Laura E Marshall; Andrew E Scott; Isobel H Norville; Peter J Myler; Ulrike Holzgrabe; Nicholas J Harmer; Mitali Sarkar-Tyson
Journal:  J Antimicrob Chemother       Date:  2022-05-29       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.